Cumulus Neuroscience Ltd.

Cumulus Neuroscience are developing faster, more effective tools to help their partners solve the biggest healthcare challenges in neurodegeneration and psychiatry. They have created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients.

All Portfolio Companies
Location
UK/EU
Fund
DDF-1